Table 4.
Symptoms of IBD Patients With a Confirmed Diagnosis of COVID-19 in the Overall Population
| Symptoms | N (%) |
|---|---|
| Fever | 217/449 (48.3) |
| Cough | 209/449 (46.5) |
| Diarrhea | 92/449 (20.5) |
| Dyspnea | 55/449 (10.5) |
| Nausea | 40/449 (8.9) |
| Abdominal pain | 39/449 (8.7) |
| Vomiting | 39/449 (8.7) |
| Fatigue | 39/449 (8.7) |
| Myalgia | 35/449 (7.8) |
| Dysgeusia | 23/449 (5.1) |
| Sore throat | 21/449 (4.7) |
| Rhinopharyngitis | 17/449 (3.8) |
| Anosmia | 12/449 (2.7) |
| Hypoxemia | 12/449 (2.7) |
| Anorexia | 8/449 (1.8) |
| Ageusia | 6/449 (1.3) |
| Headache | 3/449 (0.7) |
| Chest pain | 2/449 (0.4) |
| Night sweats | 1/449 (0.2) |
| Dysphonia | 1/449 (0.2) |
| Conjunctivitis | 1/449 (0.2) |
| Hematochezia | 1/449 (0.2) |
| Urgency | 1/449 (0.2) |
| Skin rash | 1/449 (0.2) |
| Weight loss | 1/449 (0.2) |
COVID-19, coronavirus disease 2019; IBD, inflammatory bowel disease.